The Neurotechnology Industry Organization is proud to have the support of the following visionary organizations. These organizations have committed to support NIO's mission, allowing NIO to develop a strong and unified voice to promote and advocate for advances in neurotechnology worldwide. 

ACADIA Pharmaceuticals is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. The company is located in San Diego, California.

Accera is developing novel therapeutic drugs for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Age Associated Memory Impairment. Accera is headquartered in Broomfield, Colorado.

Acorda Therapeutics is a biotechnology company whose mission is to develop and market therapies to restore neurological function in people with spinal cord injury (SCI), multiple sclerosis (MS) and related conditions of the nervous system. The company is located in Hawthorne, New York.

Acumen Pharmaceuticals is developing disease-modifying drugs that block and reverse memory loss in Alzheimer's disease. Acumen is based in South San Francisco, California.

Advanced Brain Technologies develops and distributes interactive software and music programs for the improvement of memory, attention, listening, academic skills, sensory processing, brain health, peak performance and more. The company is located in Ogden, Utah.

Adlyfe is a neurodiagnostics company that develops novel technologies for blood testing for early targets of amyloid diseases. Adlyfe is located in Rockville, Maryland.

Alexza Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The company is located in Palo Alto, California.

Alseres Pharmaceuticals is a CNS-focused biotechnology company engaged in the research and development of biopharmaceutical products for the diagnosis and treatment of central nervous system disorders including Parkinson’s Disease and spinal cord injury. The company is headquartered in Hopkinton, Massachusetts.

Amarin is a neuroscience company focused on the research, development and commercialisation of novel drugs for the treatment of central nervous system disorders. Amarin Corporation (AMRN) has headquarters in London and a research and development facility in Stirling, Scotland.

Aspect Medical Systems develops innovative brain monitoring technoloiges for assessing the brain's response to anesthetics and other neuroactive agents. Aspect's Neuroscience group is developing novel applications in neuropsychiatry, including optimization of treatments for major despression and Alzheimer's disease early detection and monitoring. The company is located in Norwood, MA.

BrainCells, Inc. is a biopharmaceutical company focused on the development of breakthrough small molecule therapeutics for diseases of the CNS. The Company's technology is based on pioneering research in the field of neurogenesis. BrainCells, Inc. is headquartered in San Diego, California.

Brain Resource Company is a global neurodiagnostics company that delivers "evidence-based" reports of brain function based on an integrated brain function database to neuropharmaceutical companies, clinicians and brain researchers. BRC's world headquarters is based in Sydney, Australia.

Ceregene is focused on the discovery and development of novel genetic therapeutics for the treatment of neurological disorders including Alzheimer's and Parkinson's disease. Ceregene is based in San Diego, CA.

Cogmed develops neuroscience-based working memory training software for improving attention, impulse control, problem solving skills and academic performance. Cogmed was founded in 2001 and is headquartered in Naperville, Illinois.

Cognitive Drug Research is a leading, global provider of automated cognitive function assessment in phase I-IV clinical trials. CDR had provided rapid, valid, and sensitive assessments of the core domains of cognitive function in over 900 trials. CDR is headquartered in the UK with offices in Melbourne, Australia, and Chicago, Illinois.

CoMentis is engaged in the discovery and development of small-molecule drugs to treat neurovascular disease such as Alzheimer’s disease, AMD and cognitive disorders. The company is located in South San Francisco, California.

Cortechs Labs creates automated methods for analyzing neuroimaging data. These tools can detect early signs of cortical atrophy in patients with neurodegenerative disease. Cortechs is located in La Jolla, California.

CNS Response is a neurodiagnostic company that leverages rEEG (referenced-EEG) technology to match mental and addiction patient physiology with treatment outcome (a biomarker system). CNS Response is located in Costa Mesa, CA.

Cyberkinetics Neurotechnology Systems, Inc. is a neurotechnology innovator focused on developing neural stimulation, sensing and processing technology to improve the lives of those with severe paralysis resulting from spinal cord injuries, neurological disorders and other conditions of the nervous system. The Company is headquartered in Foxborough, Massachusetts.

CyberLearning Technology has partnered with NASA to develop neurofeedback devices in the areas of health, learning and entertainment. Their first 'Edutainment' product, S.M.A.R.T. BrainGames, turns standard PlayStation video game platforms into powerful brain training systems. San Marcos, California.

EEG Spectrum International is a developer and distributor of neurofeedback equipment, training and resources that provide the most comprehensive and complete tools to help clinicians and their clients advance human potential. The company is headquartered in Canoga Park, CA.

Ellman Innovations designs, manufactures, educates and globally markets patented radiowave technology for intracranial and spinal surgery. The privately held company is located in Oceanside, New York.

EnVivo Pharmaceuticals is a biopharmaceutical company dedicated to discovering and developing drugs for central nervous system (CNS) disorders, currently focusing on Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and Spinocerebellar ataxias. Envivo is headquartered in Watertown, Massachusetts.

Innovative NeuroTechnologies is a discovery-stage biotechnology company that seeks diagnostic and therapeutic solutions to major human central nervous system (CNS) disorders, particularly in the area of neurodegeneration. The company is headquartered in Irvine, California.

Medivation is a biopharmaceutical company that acquires promising technologies in the late preclinical development phase and develops them quickly and cost-effectively with a focus on Alzheimer’s disease, Huntington’s disease and hormone-refractory prostate cancer.

Neurologix is a development-stage company engaged in the research and development of proprietary treatments for disorders of the brain and central nervous system utilizing gene therapies. Neurologix in Fort Lee, New Jersey.

NeuroNova is a therapeutic drug development company focused on neurogenesis for the treatment of disorders of the central nervous system. NeuroNova has three compounds in late preclinical development, two for Parkinson’s disease and one for a neurodegenerative orphan disease. NeuroNova is headquartered in Stockholm, Sweden.

NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders by responsive brain stimulation. The company's initial focus is the treatment of epilepsy. NeuroPace is located in Mountain View, California.

NeuroScience Associates (NSA) provides mass production neurohistologic services through MultiBrain® Technology which enables NSA to section and stain up to 40 neuronal tissues simultaneously. NSA is headquartered in Knoxville, TN.

NeuroProtect is developing novel therapeutics to protect against and treat stroke injury. NPI was founded for the purpose of discovering and developing new therapeutics for the treatment of stroke. The company is located in Tigard, Oregon.

Northstar Neuroscience is a medical device company focused on developing neurostimulation therapies to treat neurological injury, disorder and disease. The company is located in Seattle, Washington.

Posit Science develops science-based brain health programs. The company works with more than 50 brain scientists from leading universities around the world to create training programs that enhance cognitive performance. The company is headquartered in San Francisco, California.

RemeGenix is a neuropharmaceutical company specializing in the development and commercialization of therapies for Alzheimer’s disease, dementia and traumatic brain injury. RemeGenix is located in Rockville, Maryland.

Sound Pharmaceuticals is a neuropharmaceutical company focused on developing the first drugs to treat hearing loss and brain injury. Sound Pharmaceuticals is headquartered in Seattle, Washington.

StemCells, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of cell-based therapeutics to treat diseases of the central nervous system, liver and pancreas. The company is headquartered in Palo Alto, California.

Targacept Inc. is a biopharmaceutical company engaged in the design, discovery and development of drugs to treat multiple nervous system diseases and disorders by selectively targeting a class of receptors known as neuronal nicotinic receptors, or NNRs. Targacept is located in Winston-Salem, North Carolina.

United Therapeutics is a biotechnology company focused on the development and commercialization of unique products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases. United Therapeutics is headquartered in Silver Spring, Maryland.

Xenoport is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates for the potential treatment of central nervous system (CNS) disorders. The company is located in Santa Clara, California.

Xytis is a biotechnology company focusing on the development of clinical stage CNS drug candidates. Xytis is headquartered in Irvine, CA with its clinical development group in Nyon, Switzerland.

Neuroscience Research Centers

Allen Institute for Brain Science was founded in 2001 by philanthropists Paul G. Allen and Jody Patton to identify and address key issues in neuroscience, particularly those that can advance the understanding of human behavior.  The Institute's first project, the unprecedented Allen Brain Altas, is available at www.brain-map.org. The nonprofit Institute is located is Seattle, Washington.

Blanchette Rockefeller Neurosciences Institute is dedicated to the study of human memory. BRNI's primary mission is to accelerate the transfer of neurological discoveries from the lab, including diagnostic tools and treatments, directly to patients who are suffering from neurological diseases such as Alzheimer's. Senator Jay Rockefeller of West Virginia founded the institute in memory of his mother, who died of Alzheimer's disease.

CIMIT Neurotechnology Program - Center for Integration of Medicine and Innovative Technology - is a non-profit consortium of Boston area teaching hospitals, engineering schools and research laboratories where clinicians, engineers, industry leaders, scientists and the military, work in interdisciplinary teams to generate promising, leading-edge translational technologies for healthcare.

McGovern Institute for Brain Research at MIT is a research and teaching institute committed to advancing human understanding and communications. The McGovern Institute was established in February 2000 with a $350 million gift from Lore Harp McGovern and Patrick McGovern to meet one of the great challenges of modern science - the development of a deep understanding of thought and emotion in terms of their realization in the human brain.

The Mind Research Network for Neurological Discovery is a non-profit partnership committed to expanding neuroscience research by discovering new ways to understand human behavior, as well as to treat and cure brain disease and mental illness. This partnership combines more than 400 researchers and staff with an annual budget of $50 million to unlock the brain’s remaining secrets. The MRN is based in Albuquerque, New Mexico.

The Van der Veer Institute for Parkinson’s and Brain Research is focused on brain research and the clinical care of patients with Parkinson’s disease and other movement disorders. The Institute is located in Christchurch, New Zealand.

Patient Advocacy Groups, Research Foundations and Professional Societies

Accelerate Brain Cancer Cure is a not-for-profit organization with a for-profit mindset and a singular focus: to hasten the discovery of a cure for brain cancer. To date, ABC² has awarded multiple grants to world-renowned brain cancer researchers and created novel partnerships and collaborations with medical/academia, industry and government. ABC² is headquartered in Washington, DC.

The ALS Hope Foundation supports research programs leading to a cure, clinical centers of excellence, support programs for patients and care-givers, and physician education programs. The Foundation is located in Philadelphia, Pennsylvania.

Alzheimer's Drug Discovery Foundation is the only public charity singularly focused on Alzheimer’s disease drug discovery. ADDF's mission is to rapidly accelerate the development of drugs to prevent, treat and cure AD, related dementias and cognitive aging. ADDF accomplishes this by practicing a venture philanthropy investment model that bridges the worldwide funding gap between basic research and later-stage development, recycling any return on investment to support new research programs.

The Brain Aneurysm Foundation is a public charity whose mission is to provide support and educational materials to the medical community, the newly diagnosed, survivors, family members, friends and the general public regarding the facts, treatment options, and recovery process for brain aneurysms.  With the help of the medical community, remain steadfast and earnest in the pursuit of brain aneurysm research that can directly benefit those affected.

Epilepsy Therapy Project is a non-profit organization whose mission is to advance new therapies for people living with epilepsy. Founded in 2002 by a group of parents, distinguished physicians and researchers, the Epilepsy Therapy Project supports the commercialization of new therapies through direct grants and investments in promising academic and commercial projects. The organization has raised over five million dollars towards its mission.

The International Neuromodulation Society (INS) is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation - the alteration of nerve activity through the delivery of electrical stimulation or chemical agents to targeted sites of the body. INS was founded in 1989 and based in San Francisco, CA.

The International Neuroscience Network Foundation facilitates breakthrough research and development, education, and social programs that support new science and technology of the brain that translate into revolutionary clinical practices to dramatically improve global human health.

Myelin Repair Foundation is a non-profit medical research foundation dedicated to accelerating basic medical research into myelin repair treatments that will dramatically improve the lives of people suffering from multiple sclerosis (MS). The foundation is located in Saratoga, California.

NAMI (the National Alliance on Mental Illness) is the nation’s largest grassroots mental health organization dedicated to improving the lives of persons living with serious mental illness and their families.

NARSAD, The Mental Health Research Association, is the largest donor-supported philanthropy for psychiatric research in the world. Since 1987, NARSAD has awarded $215 million in research grants to 2,477 scientists in the U.S. and 25 other countries. NARSAD is headquartered in Great Neck, New York.

Neurotech Network is a non-profit organization focusing on users and potential users of neurodevices. Charged with a mission to provide information to and for the users and potential users of neurodevices and to encourage both the growth and the direction of developments in the neurotechnology industry. The Neurotech Network is headquartered in Tampa, Florida.

Parkinson's Research Foundation is a nonprofit health organization providing Parkinson's research, information and advocacy. The mission of the organization is to cure Parkinson's and to improve the lives of all people affected by the disease. The foundation is headquartered in Sarasota, Florida.

Venture Capital Firms

Brain Trust Accelerator Fund focuses on early stage investments that address the diagnosis and treatment of brain related diseases. Brain Trust Accelerator Fund is headquartered in Burlingame, CA.

NeuroVentures is a specialty venture capital firm dedicated to investing in companies focused on the discovery, development and marketing of new drugs, medical devices and other therapeutics and technologies to treat Central Nervous System disorders.

Technology Partners is a venture capital firm that manages a total of more than $400 million of investment capital. Founded over 20 years ago, Technology Partners invests in the Life Sciences, with an emphasis on Neurotech, and in Cleantech. Technology Partners is based in Palo Alto, California.

Strategic Partners

The American Society for Experimental NeuroTherapeutics (ASENT) is an independent non-profit organization established in 1997 by leaders in academia, government, advocacy and industry to facilitate the process by which new therapies are made available to patients with neurological disorders. Its primary goal is to encourage and advance the development of improved therapies for diseases and disorders of the nervous system.

BiotechPartnering Solutions is a private business development consulting firm that advises life science companies as well as venture capitalists and private investors on partnering strategy, search, due diligence, deal structure and transaction negotiation. The company is headquartered in Miami, Florida.

Buchanan Ingersoll & Rooney PC (BIR) represents the policy, advocacy, business development and legal interests of life science and healthcare industries. The firm has more than 550 attorneys and government relations professionals practicing throughout the United States.

Feinstein Kean Healthcare is a wholly owned subsidiary of Ogilvy Public Relations Worldwide, specializes in integrated corporate and product communications for life sciences and healthcare companies and organizations. The firm's portfolio of clients includes the full spectrum of emerging therapeutic and technology platform companies; four of the world's five largest pharmaceutical companies; government agencies; and policy organizations.

K&L Gates represents the public policy and regulatory interests of the neurotechnology industry in Washington, D.C. The firm’s more than 1400 attorneys practice across broad areas of the law, handling complex business transactions, litigation and intellectual property matters, as well as governmental, regulatory and public policy work. The firm operates across North America, Europe and Asia.

NeuroInsights, the neurotech market authority, helps investors, industry executives and the public understand and profit from the rapid growth of drug, device and diagnostic companies treating brain and nervous system-related illnesses by providing neurotech industry newsletters, comprehensive market reports, neurotech investment conferences and strategic advisory services.

NeuroInvestment provides independent and comprehensive information regarding companies developing novel drug, cell and gene therapies for disorders of the central and peripheral nervous system.

Neurotech Reports is dedicated to providing business and technology professionals up-to-date and forward-looking information about the field of neurotechnology and future developments that will affect the venture capital, research, and start-up communities.

Nixon Peabody LLP is one of the largest law firms in the United States. With more than 600 attorneys collaborating across 15 major practice areas in 16 office locations, including Boston, New York, Rochester, San Francisco, and Washington, DC, the firm’s size, diversity, and advanced technological resources enable it to offer comprehensive legal services to individuals and organizations of all sizes in local, state, national and international matters.

The Center for Neurotechnology Studies (CNS) is a research center within the Potomac Institute for Policy Studies, a nonpartisan, not-for-profit public policy research institute. The mission of CNS is to advocate and support the responsible development of neurotechnology, provide support to government agencies pursuing neurotechnology, and shepherd constructive public discourse on ethical, legal, and social issues associated with emerging neurotechnologies.